UDOSTĘPNIJ

Używanie NRT w Japonii

Wielojęzyczna baza danych jest na wczesnym etapie beta - zgłoś wszelkie zauważone problemy.
Japan Background
Źródło danych: 2022.   Strona zaktualizowana: 2026-05-26

Nicotine Replacement Therapy (NRT) is legally allowed in Japan including the sale and purchase of NRT products without a prescription from pharmacies. NRT products are included on the country’s essential drugs list, and the government partially covers NRT cost. The market size of NRT products in Japan was estimated to be 77.7 million € in 2019.

Promocja produktu

77.7 million €
1
2019
4.2 €
1
2019
Źródła:
  1. Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019

Regulacje

Źródła:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-jpn.pdf?sfvrsn=acd22c8a_3&download=true. Accessed: 9 December 2025.

Dostępność

Tak
1
2022
Tak
1
2022
Year Value Reference/Comment
2019 Tak 1A
2022 Tak 1B
Źródła:
  1. WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
  2. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-jpn.pdf?sfvrsn=acd22c8a_3&download=true. Accessed: 9 December 2025.
Tak
2
2019
Year Value Reference/Comment
2019 Apteka 1A
2022 Apteka 1B
Źródła:
  1. WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
  2. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-jpn.pdf?sfvrsn=acd22c8a_3&download=true. Accessed: 9 December 2025.
Źródła:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-jpn.pdf?sfvrsn=acd22c8a_3&download=true. Accessed: 9 December 2025.
  2. WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).

Formalne wsparcie

Tak NRT znajduje się na krajowej liście leków podstawowych.
1 A
2022
Źródła:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-jpn.pdf?sfvrsn=acd22c8a_3&download=true. Accessed: 9 December 2025.
Komentarze:
  1. NRT cost is partially covered by the government.

Publications


The Global State of Tobacco Harm Reduction 2024: Raport sytuacyjny

This Briefing Paper summarises The Global State of Tobacco Harm Reduction 2024: A Situation Report, which uses the latest evidence and new data projections to report on the current global THR situation and its potential to rapidly reduce the burden of disease and mortality associated with risky tobacco use.


Na czym polega redukcja szkód wywołanych paleniem tytoniu?

Tobacco harm reduction is a potentially life-saving intervention for millions of people across the world who use high-risk tobacco products, offering them the chance to switch to a range of safer nicotine products. Here, we provide a detailed introduction to the principles, history and evidence for this vital public health strategy.

The GSTHR database is updated regularly by our team. However, please be aware that the information we provide does not constitute legal advice. We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product categories can change at short notice and with little publicity. If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region, you should verify the information independently. If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details and any references and we will rectify any errors.